Search clinical trials for: XR9576 (Tariquidar)

Total 11 results

National Cancer Institute (NCI)

Completed

Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer

Adrenal Cortex Neoplasms

United States
National Cancer Institute (NCI)

Completed

PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy

Cancer

United States
National Cancer Institute (NCI)

Completed

Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

Lung Neoplasms | Ovarian Neoplasms | Cervix Neoplasms | Renal Neoplasms

United States
National Cancer Institute (NCI)

Completed

Phase I Trial of Tariquidar (XR9576) in Combination With Doxorubicin, Vinorelbine, or Docetaxel in Pediatric Patients With Solid Tumors

Sarcoma | Wilms' Tumor | Refractory Cancer | Adenaocortical Carcinoma | Coldrhood Cancer

United States
National Cancer Institute (NCI)

Completed

Vinorelbine and XR9576 to Treat Cancer

Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer

United States
Washington University School of Medicine

Terminated

Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers

Neuropathic Pain

United States
QLT Inc.

Terminated

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Stage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
QLT Inc.

Terminated

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Paclitaxel/Carboplatin as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Stage IV Non-small Cell Lung Cancer | Stage IIIb Non-small Cell Lung Cancer
European Organisation for Research and Treatment...

Completed

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Breast Cancer

France, Belgium
Washington University School of Medicine

Completed

Tariquidar-ondansetron Combination in Neuropathic Pain

Neuropathic Pain

United States
Bayer

Completed

Metabolism Study to Investigate the Impact of a Sequential Oral Contraceptive

Contraception

Germany

3

Subscribe